ReviewCurrent hematologic malignancy reports2020

The Next Generation of JAK Inhibitors: an Update on Fedratinib, Momelotonib, and Pacritinib.

Anand A Patel et al.PubMed ↗Publisher ↗

No numbers read from the abstract.